Table 1 The descriptive epidemiological data of the examined flocks for ACoV detection in the seven Upper Egypt governorates
Flock location | Poultry farms | Flock type | Flock age | Year | Vaccination programs | Mortality % | No. of birds | Collected samples | Signs and postmortem lesions | |||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Beni-Seuf | 10 | Broilers, | 20–35 days | 2023 | H120 (GI-1) + 4/91(GI-13) + Inactivated vaccine (GI-1) | 9 | 9000–12000 | Lung | Trachea | Kidney | Oviduct | Severe respiratory manifestations, congested lung, and trachea with caseous exudates |
Breeders | 23–61 weeks | 3000–7000 | 44 | 31 | 15 | – | ||||||
El-Mina | 18 | Broilers, | 23–31 days | 2023 | IB Primer (GI-1,12) + 4/91(GI-13) + Inactivated vaccine (GI-1) | 10 | 7000–10,000 | 43 | 32 | 12 | 10 | Respiratory manifestations, egg production disorders, nephropathogenic lesions, congested lung, and trachea, degenerated ovaries, and swollen oviducts |
Breeders Layers | 22–60 weeks | 4000–9000 | ||||||||||
Assuit | 29 | Broilers | 25–35 days | 2023 2024 | IB Primer (GI-1,12) + IB VarII (GI-23) + Inactivated vaccine (GI-1) | 10 | 12,000–15000 | 60 | 23 | 17 | 35 | |
Breeders, layers | 22–62 weeks | 9000–15000 | ||||||||||
Sohag | 12 | Broilers | 20–30 days | 2023 2024 | H120 (GI-1) + IB VarII (GI23) + Inactivated vaccine (GI-1) | 8 | 9000–11000 | 50 | 23 | 7 | 13 | |
Breeders layers | 23–62 weeks | 2000–7000 | ||||||||||
Qena | 7 | Broilers | 23–35 days | 2024 | H120 (GI-1) + 4/91 (GI-13) + Inactivated vaccine (GI-1) | 9 | 8000–12000 | 29 | 20 | 9 | 5 | |
Breeders Layers | 22–61 weeks | 4000–8000 | ||||||||||
Aswan | 6 | Broilers | 22–33 days | 2023 | IB Primer (GI-1,12) + 4/91(GI-13) and some are non-vaccinated | 8 | 5000–7000 | 10 | 12 | 8 | – | Severe respiratory manifestations, congested lung, and trachea with caseous exudates |
New Valley | 8 | Broilers | 20–35 days | 2024 | IB Primer (GI-1,12) + IB VarII (GI-23) and some are non-vaccinated | 8 | 4000–6000 | 36 | 25 | 15 | – | |